I beg to move,

That the draft Infected Blood Compensation Scheme (Amendment) Regulations 2026, which were laid before this House on 18 June, be approved.

Before I begin the debate, I do want to pause and reflect on the reason that we are once again here today. Thousands of people had unimaginable suffering and hardship inflicted upon them through the use of infected blood. There are thousands of individual stories—in recent years, I have had the solemn privilege to listen to many of them—of how lives were upturned, changed and, in some cases, tragically lost. I know many Members across the House will, as they always do in these debates, very movingly share their constituents’ stories, and it is important that we keep those at the forefront of our minds. It is also essential that we base our work on these stories, and that the compensation scheme reflects the lived experience of those to whom it seeks to bring justice.

I would like to briefly update the House on the delivery of compensation. Since it opened in 2024, the compensation service—the Infected Blood Compensation Authority—has contacted all infected people registered with the support scheme to start their claim. By December last year, it had opened its service to all cohorts, including to affected people. It has made offers of over £2.7 billion and paid out over £2.1 billion, in addition to the £1.4 billion that has already been paid in interim compensation.